Condensed Consolidated Balance Sheets - USD ($)		Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents		$ 9,840,177	$ 8,446,158
Unbilled revenue			171,254
Research and development incentives receivable, current			23,894
Deferred issuance cost		126,385
Prepaid expenses and other current assets		340,330	866,014
Total current assets		10,306,892	9,507,320
Security deposit		22,777	22,777
Office furniture and equipment, net		7,162	11,927
Right-of-use lease assets		140,148	229,834
Research and development incentives receivable, net of current portion			25,468
Total assets		10,476,979	9,797,326
Current liabilities:
Accounts payable		891,227	1,111,226
Accrued expenses		1,363,235	2,418,002
Accrued compensation		84,362	251,115
Lease liabilities, current		132,114	121,765
Convertible debt		2,059,309	2,250,000
Total current liabilities		4,530,247	6,152,108
Non-current liabilities:
Convertible debt			1,010,934
Lease liabilities, net of current portion		11,544	111,862
Total liabilities		4,541,791	7,274,904
Commitments and contingencies (Note 6)
Shareholders' equity:
Preferred stock, 350,000 shares authorized; none issued or outstanding at September 30, 2024 and December 31, 2023, respectively
Common stock, $.001 par value; 75,000,000 shares authorized; 2,295,304 and 648,761 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively	[1]	2,295	649
Additional paid-in capital	[1]	236,878,806	228,203,706
Accumulated other comprehensive income		37,473	22,243
Accumulated deficit		(230,983,386)	(225,704,176)
Total shareholders' equity		5,935,188	2,522,422
Total liabilities and shareholders' equity		$ 10,476,979	$ 9,797,326

[1] Adjusted to reflect the reverse stock split of one-for-sixteen effective June 5, 2024